SFX by Ex Libris Inc.

Title:	Antitumor efficacy and acute toxicity of the novel dipeptide melphalanyl-p-L-fluorophenylalanine ethyl ester (J1) in vivo
Source:	Investigational New Drugs [0167-6997] Gullbo, Joachim yr:2004

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gullbo, J. "Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan." Anti-cancer drugs 14.8 (2003): 617-624.
description	2.	Hollingshead, MG G. "In vivo cultivation of tumor cells in hollow fibers." Life Sciences 57.2 (1995): 131-41.
description	3.	Zache, N. "PRIMA-1(MET) inhibits growth of mouse tumors carrying mutant p53." Cellular oncology 30.5 (2008): 411-418.
description	4.	Gullbo, J. "Structure-activity relationship for alkylating dipeptide nitrogen mustard derivatives." Oncology research 14.3 (2003): 113-132.
description	5.	Lambert, Jeremy M. "PRIMA-1 reactivates mutant p53 by covalent binding to the core domain." Cancer cell 15.5 (2009): 376-388.
description	6.	Wang, W. "Restoration of p53 to limit tumor growth." Current opinion in oncology 20.1 (2007): 90-6.
description	7.	Bouchet, B. "p53 as a target for anti-cancer drug development." Critical reviews in oncology/hematology 58.3 (2006): 190-207.
description	8.	Brozic, P. "Discovery of new inhibitors of aldo-keto reductase 1C1 by structure-based virtual screening." Molecular and Cellular Endocrinology 301.1-2 (2009): 245-250.
description	9.	Gullbo, J. "Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2." Molecular cancer therapeutics 2.12 (2003): 1331-1339.
description	10.	Larsson, R. "Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients." The British Journal of Cancer 78.3 (1998): 328-.
description	11.	Xu, Ze-Qi Q. "In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model." Bioorganic & medicinal chemistry letters 9.2 (1999): 133-138.
description	12.	Komiya, T. "Ritterazine B, a new cytotoxic natural compound, induces apoptosis in cancer cells." Cancer chemotherapy and pharmacology 51.3 (2003): 202-8.
description	13.	Moschella, F. "Shifting gene expression profiles during ex vivo culture of renal tumor cells: Implications for cancer immunotherapy." Oncology research 14.3 (2003): 133-145.
description	14.	Kapiteijn, E. "Mechanisms of oncogenesis in colon versus rectal cancer." The Journal of pathology 195.2 (2001): 171-8.
description	15.	Shen, J. "PRIMA-1(MET) induces mitochondrial apoptosis through activation of." Oncogene 27.51 (2008): 6571-.
description	16.	Bykov, VJ. "Reactivation of mutant p53 and induction of apoptosis in human tumor cells." The Journal of biological chemistry 280.34 (2005): 30384-.
description	17.	Yu, D. "Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA." Nature 450.7167 (2007): 299-303.
description	18.	Gustafsson, G. "Flexible light-emitting diodes made from soluble conducting polymers." Nature 357.6378 (1992): 477-479.
description	19.	Vassilev, Lyubomir T. "In vivo activation of the p53 pathway by small-molecule antagonists of MDM2." Science 303.5659 (2004): 844-848.
description	20.	Glasmacher, E. "Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression." Nature Immunology 11.8 (2010): 725-733.